|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.66 USD | -2.16% |
|
-1.78% | -11.53% |
| 05-14 | Transcript : OptimizeRx Corporation, Q1 2024 Earnings Call, May 14, 2024 | |
| 05-14 | OptimizeRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
OptimizeRx Corporation reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 19.69 million compared to USD 13 million a year ago. Net loss was USD 6.9 million compared to USD 6.4 million a year ago.
Basic loss per share from continuing operations was USD 0.38 compared to USD 0.37 a year ago. Diluted loss per share from continuing operations was USD 0.38 compared to USD 0.37 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -11.53% | 231M | |
| +26.70% | 451B | |
| +33.30% | 280B | |
| +3.17% | 133B | |
| +28.11% | 92.61B | |
| +7.98% | 93.33B | |
| +65.13% | 61.54B | |
| +13.70% | 45.98B | |
| +22.96% | 36.9B | |
| -4.73% | 34.01B |
OPTIMIZERX CORPORATION 
